11.1 Information on toxicological effects
Acute toxicity
Oral: No data available
LC50 Inhalation - 4 h - 3 mg/l - vapor (Acute toxicity estimate)
LD50 Dermal - 300 mg/kg
Skin corrosion/irritation
Remarks: No data available
Serious eye damage/eye irritation
Remarks: No data available
Respiratory or skin sensitization
Classified based on available data. For more details, see section 2
Germ cell mutagenicity
Classified based on available data. For more details, see section 2
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
General signs of toxicity for overexposure to tetraalkyl tin compounds include muscular weakness and paralysis, leading to respiratory failure, tremors, convulsive movements, closure of the eyelids, and photophobia. Histologically, tetraalkyl tin compounds show a decrease in cytoplasmic basophilia of the liver, chromatolysis of the Purkinje cells of the cerebellum, and increase in the water content of the brain and spinal cord., Dermatitis,
Nausea, Dizziness, Headache, To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.